Developing light-activated nanomotors for targeted drug delivery and treatment
In Silico Study and Optimization of Molecular Nanomotors for Membrane Photopharmacology
This study is exploring how tiny light-activated motors can help deliver medicine more effectively for conditions like cancer and tough infections, aiming to make treatments work better and cause fewer side effects.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | California State University Long Beach NIH-funded |
| Lab location | 1 site (Long Beach, United States) |
| Project ID | NIH-11089455 on NIH RePORTER |
What this research studies
This research focuses on creating advanced molecular nanomotors that can be activated by light to improve drug delivery and treatment for conditions like cancer and antibiotic-resistant infections. By using computer modeling, the team will study how these nanomotors disrupt cell membranes and induce cell death, which could lead to more effective therapies with fewer side effects. The goal is to enhance drug selectivity and reduce the environmental impact of pharmaceuticals by optimizing these nanomotors for clinical applications.
Who could benefit from this research
Good fit: Ideal candidates for this research would include patients with cancer or those suffering from infections caused by antibiotic-resistant bacteria.
Not a fit: Patients with conditions that do not involve cancer or bacterial infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted treatments for cancer and bacterial infections, minimizing side effects and overcoming drug resistance.
How similar studies have performed: While the use of nanomotors in drug delivery is a relatively novel approach, preliminary studies have shown promise in similar applications, indicating potential for success.
Where this research is happening
Long Beach, United States
- California State University Long Beach — Long Beach, United States (Active)
Researchers
- Principal investigator: Tapavicza, Enrico — California State University Long Beach
- Study coordinator: Tapavicza, Enrico
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.